Related Experiment Video
Updated: Jun 2, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Coexistence of neuroleptic malignant syndrome and a hyperosmolar hyperglycemic state
Chung-Wei Yang1, Ching Lu, Chih-Cheng Wu
1Department of Internal Medicine, Hsin Chu General Hospital, School of Medicine, National Yang-Ming University, Hsinchu City 300, Taiwan.
Abstract:
Neuroleptic malignant syndrome (NMS) is a rare idiosyncratic disorder characterized by muscle rigidity, hyperthermia, autonomic dysfunction, and altered consciousness. Although the incidence of NMS is low, it may be fatal if early recognition is delayed. There are a variety of precipitating factors for NMS including systemic illness and dehydration. The combination of NMS with systemic illness can be difficult to diagnose because the systemic illness may mask the coexistence of NMS. We report a patient with hyperosmolar hyperglycemic state with coexistent NMS to remind physicians that hyperosmolar hyperglycemic state may precipitate the development of NMS in patients receiving neuroleptics.
Related Concept Videos
Hyperosmolar Hyperglycemic State
Hypoglycemia and Glucagon
Complications of Diabetes Mellitus
Diabetic Ketoacidosis ll: Pathophysiology
Hyperglycemia
Diabetic Ketoacidosis l: Introduction
